Add to ORKGP53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinoma
<p>Clinical, pathological and <i>TP53</i> gene mutational data of areas with extensive p53 IHC overe...
Somatic TP53 gene mutations are common in different cancers, occurring in almost half of ovarian tum...
International audienceThe TP53 tumor suppressor gene is frequently mutated in human cancers. An anal...
<p><strong>Background:</strong> Basal-like breast cancer is difficult to treat with standard regimen...
Metastatic melanoma is a fatal disease with poor prognosis. Ever since targeted therapy against onco...
Molecular profiling with next generation sequencing (NGS) delivers key information on mutant gene se...
BACKGROUND: Mutations causing p53 inactivation are among the most common genetic alterations in huma...
The tumor suppressor gene TP53 has been localized to the short arm of chromosome 17. It is frequentl...
Abstract Background Mutations in the TP53 gene are ex...
Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumo
Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting componen...
Objective(s) P53 is an important tumor suppressor, which is mutated in later stages of many cancers ...
AbstractThe tumor suppressor TP53 gene is one of the most frequently mutated in different types of h...
Additional file 2: Table S2. Clinical and histopathological characteristics of tumors
Although evidence suggests an inverse relationship between microsatellite instability and p53 altera...
<p>Clinical, pathological and <i>TP53</i> gene mutational data of areas with extensive p53 IHC overe...
Somatic TP53 gene mutations are common in different cancers, occurring in almost half of ovarian tum...
International audienceThe TP53 tumor suppressor gene is frequently mutated in human cancers. An anal...
<p><strong>Background:</strong> Basal-like breast cancer is difficult to treat with standard regimen...
Metastatic melanoma is a fatal disease with poor prognosis. Ever since targeted therapy against onco...
Molecular profiling with next generation sequencing (NGS) delivers key information on mutant gene se...
BACKGROUND: Mutations causing p53 inactivation are among the most common genetic alterations in huma...
The tumor suppressor gene TP53 has been localized to the short arm of chromosome 17. It is frequentl...
Abstract Background Mutations in the TP53 gene are ex...
Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumo
Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting componen...
Objective(s) P53 is an important tumor suppressor, which is mutated in later stages of many cancers ...
AbstractThe tumor suppressor TP53 gene is one of the most frequently mutated in different types of h...
Additional file 2: Table S2. Clinical and histopathological characteristics of tumors
Although evidence suggests an inverse relationship between microsatellite instability and p53 altera...
<p>Clinical, pathological and <i>TP53</i> gene mutational data of areas with extensive p53 IHC overe...
Somatic TP53 gene mutations are common in different cancers, occurring in almost half of ovarian tum...
International audienceThe TP53 tumor suppressor gene is frequently mutated in human cancers. An anal...